Insider Files Form 144 for 900 XYZ Shares; 26,859 Shares Sold Recently

Rhea-AI Filing Summary

The filing is a Form 144 notice for proposed sale of 900 shares of common stock through Morgan Stanley Smith Barney on the NYSE with an aggregate market value of $68,616. The shares were acquired as restricted stock on 08/20/2024 and payment was recorded on that same date. The filer, named in the transaction records as Dhananjay Prasanna, has completed multiple sales of the issuer's common stock in the past three months, totaling 26,859 shares sold across dates from 06/16/2025 to 08/25/2025 for aggregated gross proceeds shown in the filing. The form includes the seller's representation that they are not aware of undisclosed material adverse information.

Positive

• Required Form 144 fields are provided: broker name, class, quantity, acquisition details and seller attestation are included
• Acquisition type disclosed: the 900 shares were acquired as restricted stock on 08/20/2024, giving clear provenance of the shares

Negative

• Significant recent sales by the same filer: the filing documents 26,859 shares sold in the past three months, which may concern investors tracking insider dispositions
• No issuer name provided in the form body (issuer fields are blank), limiting context about the underlying company and the significance of the sales

Insights

Securities Analyst

TL;DR: Insider sale notice for 900 restricted shares amid prior outsized disposals totalling 26,859 shares; likely routine but notable for volume.

The Form 144 documents a planned open-market sale of 900 shares valued at $68,616 executed via Morgan Stanley Smith Barney, and confirms those shares originated as restricted stock on 08/20/2024. The filing also lists 12 prior transactions by the same seller in the past three months totaling 26,859 shares and substantial gross proceeds. From a trading-impact perspective, the single-block 900-share notice is small versus the reported outstanding share count (609,584,000) but the cumulative recent disposals indicate ongoing liquidity actions by the holder. No issuer-specific financial results or other disclosures are included in the filing.

Corporate Governance Expert

TL;DR: Form 144 compliance appears complete: acquisition details, broker, recent sales and seller representation are provided.

The notice supplies required items: broker identification, class and quantity of securities, acquisition date and nature (restricted stock), and a seller attestation regarding material non-public information. The inclusion of multiple prior sales in the reporting period provides transparency about the seller's recent dispositions. The filing does not disclose any trading plan adoption date or other 10b5-1 information; absence of such a date is explicitly shown as blank in the remarks section.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	900	68616.00	609584000	09/02/2025	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	08/20/2024	Restricted Stock	Issuer			900	08/20/2024	Not Applicable

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
DHANANJAY PRASANNA 1955 Broadway, Suite 600 Oakland CA 94612	Common	08/25/2025	400	32000.00
DHANANJAY PRASANNA 1955 Broadway, Suite 600 Oakland CA 94612	Common	08/21/2025	5659	417181.48
DHANANJAY PRASANNA 1955 Broadway, Suite 600 Oakland CA 94612	Common	08/15/2025	3600	274284.00
DHANANJAY PRASANNA 1955 Broadway, Suite 600 Oakland CA 94612	Common	08/08/2025	400	32796.00
DHANANJAY PRASANNA 1955 Broadway, Suite 600 Oakland CA 94612	Common	08/01/2025	3600	269748.00
DHANANJAY PRASANNA 1955 Broadway, Suite 600 Oakland CA 94612	Common	07/23/2025	800	64000.00
DHANANJAY PRASANNA 1955 Broadway, Suite 600 Oakland CA 94612	Common	07/17/2025	800	56000.00
DHANANJAY PRASANNA 1955 Broadway, Suite 600 Oakland CA 94612	Common	07/15/2025	2800	190568.00
DHANANJAY PRASANNA 1955 Broadway, Suite 600 Oakland CA 94612	Common	07/02/2025	800	56000.00
DHANANJAY PRASANNA 1955 Broadway, Suite 600 Oakland CA 94612	Common	07/01/2025	2800	189672.00
DHANANJAY PRASANNA 1955 Broadway, Suite 600 Oakland CA 94612	Common	06/30/2025	2400	161376.00
DHANANJAY PRASANNA 1955 Broadway, Suite 600 Oakland CA 94612	Common	06/16/2025	2800	177828.00

144: Remarks and Signature

Remarks

Date of Notice

Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What does the Form 144 filed for XYZ report?

It reports a proposed sale of 900 common shares through Morgan Stanley Smith Barney on the NYSE with aggregate market value of $68,616.

When and how were the 900 shares acquired?

The shares were acquired as restricted stock on 08/20/2024, with payment recorded on that date.

How many shares has the filer sold recently according to this filing?

The filing lists 12 sales totaling 26,859 shares during 06/16/2025–08/25/2025 with the gross proceeds reported for each sale.

Which broker will execute the proposed sale?

Morgan Stanley Smith Barney LLC Executive Financial Services is listed as the broker and the sale is noted for execution on the NYSE.

Does the filing indicate a 10b5-1 trading plan date?

No; the form's field for plan adoption or instruction date is blank in the remarks section.